We serve Chemical Name:Ethyl 1-Methyl-4-oxocyclohexanecarboxylate CAS:147905-77-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Ethyl 1-Methyl-4-oxocyclohexanecarboxylate
CAS.NO:147905-77-9
Synonyms:ethyl 4-keto-1-methylcyclohexanoate;1-methyl-4-oxo-cyclohexanecarboxylic acid ethyl ester;ethyl 1-methyl-4-oxocyclohexanecarboxylate;1-Methyl-4-oxo-cyclohexancarbonsaeure-aethylester;ethyl 1-methyl-4-oxo-1-cyclohexanecarboxylate
Molecular Formula:C10H16O3
Molecular Weight:184.23200
HS Code:2918300090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:43.37000
Exact Mass:184.11000
LogP:1.69890
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like ethyl 4-keto-1-methylcyclohexanoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 1-methyl-4-oxo-1-cyclohexanecarboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ethyl 4-keto-1-methylcyclohexanoate Use and application,1-Methyl-4-oxo-cyclohexancarbonsaeure-aethylester technical grade,usp/ep/jp grade.
Related News: Biogen hiked its revenue guidance for the year, saying it expects total sales of $10.65 billion to $10.85 billion this year. That’s up from its previous estimates of $10.45 billion to $10.75 billion. The new forecast assumes “modest” revenue from Aduhelm in 2021, ramping up thereafter, the company said. 1-(4-Bromo-phenyl)-7-chloro-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid ethyl ester manufacturers CHMP also recommended for approval Sanofi and Genzyme’s new Pompe disease drug, known in Europe as Nexviadyme (avalglucosidase alfa). Pompe disease is a rare, inherited disorder caused by the buildup of glycogen in the body’s cells. ethyl (S)-2-(tert-butoxycarbonylamino)-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionate suppliers Since it emerged as a shareholder of GSK in April, Elliott has reportedly been trying to gin up investor support to move Walmsley to the consumer health spinoff rather than to let her lead the new GSK after the separation. 3-((4-chlorophenoxy)methyl)-6-(5-(4-nitrophenyl)thiophen-2-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine vendor & factory.
